Surrogate endpoints in trials-a call for better reporting

被引:5
作者
Ciani, Oriana [1 ]
Manyara, Anthony M. [2 ]
Taylor, Rod S. [2 ,3 ]
机构
[1] SDA Bocconi Sch Management, Milan, Italy
[2] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
来源
BMJ-BRITISH MEDICAL JOURNAL | 2022年 / 378卷
基金
英国医学研究理事会;
关键词
CLINICAL-TRIALS; PROTOCOL; STANDARD;
D O I
10.1136/bmj.o1912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 17 条
  • [1] Understanding randomised controlled trials
    Akobeng, AK
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (08) : 840 - 844
  • [2] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
    Atkinson, AJ
    Colburn, WA
    DeGruttola, VG
    DeMets, DL
    Downing, GJ
    Hoth, DF
    Oates, JA
    Peck, CC
    Schooley, RT
    Spilker, BA
    Woodcock, J
    Zeger, SL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 89 - 95
  • [3] Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT)
    Butcher, Nancy J.
    Monsour, Andrea
    Mew, Emma J.
    Szatmari, Peter
    Pierro, Agostino
    Kelly, Lauren E.
    Farid-Kapadia, Mufiza
    Chee-a-tow, Alyssandra
    Saeed, Leena
    Monga, Suneeta
    Ungar, Wendy
    Terwee, Caroline B.
    Vohra, Sunita
    Fergusson, Dean
    Askie, Lisa M.
    Williamson, Paula R.
    Chan, An-Wen
    Moher, David
    Offringa, Martin
    [J]. TRIALS, 2019, 20 (1)
  • [4] SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials
    Calvert, Melanie
    King, Madeleine
    Mercieca-Bebber, Rebecca
    Aiyegbusi, Olalekan
    Kyte, Derek
    Slade, Anita
    Chan, An-Wen
    Basch, E.
    Bell, Jill
    Bennett, Antonia
    Bhatnagar, Vishal
    Blazeby, Jane
    Bottomley, Andrew
    Brown, Julia
    Brundage, Michael
    Campbell, Lisa
    Cappelleri, Joseph C.
    Draper, Heather
    Dueck, Amylou C.
    Ells, Carolyn
    Frank, Lori
    Golub, Robert M.
    Griebsch, Ingolf
    Haywood, Kirstie
    Hunn, Amanda
    King-Kallimanis, Bellinda
    Martin, Laura
    Mitchell, Sandra
    Morel, Thomas
    Nelson, Linda
    Norquist, Josephine
    O'Connor, Daniel
    Palmer, Michael
    Patrick, Donald
    Price, Gary
    Regnault, Antoine
    Retzer, Ameeta
    Revicki, Dennis
    Scott, Jane
    Stephens, Richard
    Turner, Grace
    Valakas, Antonia
    Velikova, Galina
    von Hildebrand, Maria
    Walker, Anita
    Wenzel, Lari
    [J]. BMJ OPEN, 2021, 11 (06):
  • [5] Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension
    Calvert, Melanie
    Blazeby, Jane
    Altman, Douglas G.
    Revicki, Dennis A.
    Moher, David
    Brundage, Michael D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 814 - 822
  • [6] Improving the use of hospice services in nursing homes - A randomized controlled trial
    Casarett, D
    Karlawish, J
    Morales, K
    Crowley, R
    Mirsch, T
    Asch, DA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02): : 211 - 217
  • [7] SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Altman, Douglas G.
    Laupacis, Andreas
    Gotzsche, Peter C.
    Krleza-Jeric, Karmela
    Hrobjartsson, Asbjorn
    Mann, Howard
    Dickersin, Kay
    Berlin, Jesse A.
    Dore, Caroline J.
    Parulekar, Wendy R.
    Summerskill, William S. M.
    Groves, Trish
    Schulz, Kenneth F.
    Sox, Harold C.
    Rockhold, Frank W.
    Rennie, Drummond
    Moher, David
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 158 (03) : 200 - +
  • [8] Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward
    Ciani, Oriana
    Buyse, Marc
    Drummond, Michael
    Rasi, Guido
    Saad, Everardo D.
    Taylor, Rod S.
    [J]. VALUE IN HEALTH, 2017, 20 (03) : 487 - 495
  • [9] Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study
    Ciani, Oriana
    Buyse, Marc
    Garside, Ruth
    Pavey, Toby
    Stein, Ken
    Sterne, Jonathan A. C.
    Taylor, Rod S.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [10] Drug Regulation Rosiglitazone: what went wrong?
    Cohen, Deborah
    [J]. BRITISH MEDICAL JOURNAL, 2010, 341 : 530 - 535